HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 91.6
(-0.92%)
CNY 91.6
(-0.92%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 47.33 Million CNY | 13.64% |
| 2022 | 41.65 Million CNY | -51.68% |
| 2021 | 86.19 Million CNY | 52.24% |
| 2020 | 56.61 Million CNY | -11.31% |
| 2019 | 63.83 Million CNY | 58.98% |
| 2018 | 40.15 Million CNY | 88.04% |
| 2017 | 21.35 Million CNY | 392.59% |
| 2016 | 4.33 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 6.58 Million CNY | -59.3% |
| 2024 Q2 | 16.17 Million CNY | 324.5% |
| 2024 Q1 | 3.8 Million CNY | -56.2% |
| 2023 Q3 | 17.06 Million CNY | 6.58% |
| 2023 FY | 47.33 Million CNY | 13.64% |
| 2023 Q4 | 8.69 Million CNY | -49.03% |
| 2023 Q2 | 16 Million CNY | 187.85% |
| 2023 Q1 | 5.56 Million CNY | 297.17% |
| 2022 FY | 41.65 Million CNY | -51.68% |
| 2022 Q3 | 20.11 Million CNY | 86.25% |
| 2022 Q2 | 10.79 Million CNY | -20.38% |
| 2022 Q1 | 13.56 Million CNY | 18.59% |
| 2022 Q4 | -2.82 Million CNY | -114.03% |
| 2021 FY | 86.19 Million CNY | 52.24% |
| 2021 Q4 | 11.43 Million CNY | -61.46% |
| 2021 Q3 | 29.67 Million CNY | -6.52% |
| 2021 Q2 | 31.74 Million CNY | 138.03% |
| 2021 Q1 | 13.33 Million CNY | -25.6% |
| 2020 FY | 56.61 Million CNY | -11.31% |
| 2020 Q4 | 17.92 Million CNY | -8.61% |
| 2020 Q3 | 19.61 Million CNY | -19.64% |
| 2020 Q1 | -5.33 Million CNY | -159.67% |
| 2020 Q2 | 24.4 Million CNY | 557.7% |
| 2019 FY | 63.83 Million CNY | 58.98% |
| 2019 Q4 | 8.93 Million CNY | -56.17% |
| 2019 Q3 | 20.39 Million CNY | -12.27% |
| 2019 Q2 | 23.24 Million CNY | 106.35% |
| 2019 Q1 | 11.26 Million CNY | 0.0% |
| 2018 FY | 40.15 Million CNY | 88.04% |
| 2017 FY | 21.35 Million CNY | 392.59% |
| 2016 FY | 4.33 Million CNY | 0.0% |